Jens De Vos

Title: Jens De Vos: Innovator in Cancer Treatment

Introduction

Jens De Vos is a notable inventor based in Strombeek-Bever, Belgium. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 4 patents, his work focuses on the use of radiolabelled antibody fragments for therapeutic purposes.

Latest Patents

One of Jens De Vos's latest patents involves radiolabelled antibody fragments designed for use in treating cancer. This patent outlines methods, kits, and compositions aimed at stratifying and treating subjects with cancer. The methods described include the use of a radiolabelled heavy chain variable domain derived from a heavy chain antibody, or a functional fragment thereof, serving as both a screening agent and a treatment agent. The radiolabelled fragments utilize a radioisotope that emits both gamma and beta radiation, enhancing their effectiveness in cancer therapy.

Career Highlights

Throughout his career, Jens De Vos has worked with esteemed institutions such as Vrije Universiteit Brussel and VIB VZW. His research has been pivotal in advancing the understanding and treatment of cancer, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Jens has collaborated with notable professionals in his field, including Nick Devoogdt and Tony Lahoutte. These partnerships have further enriched his research and contributed to the development of groundbreaking cancer treatment methodologies.

Conclusion

Jens De Vos stands out as a significant figure in the realm of cancer treatment innovation. His patents and collaborative efforts reflect his commitment to advancing medical science and improving the lives of those affected by cancer.